REG - Eden Research plc - Appointment of Non-Executive Director

Eden ResearchAnnouncement

02/09/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220902:nRSB0278Ya&default-theme=true

RNS Number : 0278Y  Eden Research plc  02 September 2022

2 September 2022

Eden Research Plc

("Eden" or "Company")

Appointment of Non-Executive Director

Eden Research plc (AIM: EDEN; OTCQB:  EDNSF), the AIM-quoted company focused
on sustainable biopesticides and plastic-free formulation technology for use
in the global crop protection, animal health and consumer products industries,
today announces the appointment of Richard Horsman as Non-Executive Director,
with effect from 1 September 2022.

Richard brings over 25 years of AIM and Main Market experience to the team,
having worked in both Executive and Non-Executive roles across a broad
spectrum of businesses and industries. He has experience in delivering both
organic and acquisition-based growth that will support Eden in delivering on
its strategic objectives. Richard also has hands on agricultural experience,
having owned and operated a commercial farm, and gaining a Diploma from
Plumpton Agricultural College.

Richard also holds non-executive roles at broadband, fixed line and mobile
solutions business, Toople plc, and Gardien Group, a provider of software and
services to the printed circuit board industry. Previous non-executive roles
have included AIM-listed oil exploration and technology company Tomco plc, and
specialty pharmaceutical business, Plethora Solutions plc.

Prior to his non-executive career, Richard served a 9-year tenure as CEO of
Cybit Holdings plc, a leading provider of ASP based software solutions for the
vehicle and asset management market. In this role, he defined the company's
market strategy, recruiting a team to establish a leading product and services
portfolio. Richard built Cybit to become a European market leader, with
consistent double-digit revenue and profit growth, before leading its sale to
Francisco Partners, in late 2009, which delivered a 106% premium to the share
price.

Eden Chairman Lykele van der Broek commented: "With over 25 years'
executive-level experience in both public and privately owned businesses,
Richard is a valuable addition to the Eden team. As the only AIM-listed
business focused on sustainable biopesticides, Eden is dedicated to growing
the business to meet the rising needs of farmers across the globe, who are
seeking viable alternatives to conventional chemical pesticides, as they are
increasingly regulated out of the market. Richard's wealth of knowledge and
experience will provide an additional perspective as we continue to focus on
our growth strategy and pursue opportunities across new geographies and
products lines, both organically and potentially through industry
consolidation."

Regulatory Disclosures:

In accordance with Rule 17 and Schedule 2(g) of the AIM Rules for
Companies, Richard John Horsman, aged 61, has held the following
directorships in the past five years:

 Current Directorships:              Directorships held in the past five years:
 Toople plc                          Tomco Energy plc
 Gardien (SEA) Pte. Ltd.             Ucamco NV
 J.C. Mackinlay and Co. Limited
 Altar Cottages Charity
 Crowhurst Relief in Need Charities
 High Lees Farm Partnership

 

 

For further information, contact:

 

 Eden Research plc                               www.edenresearch.com

 Sean Smith                                      01285 359 555

 Alex Abrey

 Cenkos Securities (NOMAD and broker)            020 7397 8900

 Giles Balleny / Max Gould (Corporate Finance)

 Michael Johnson (Sales)

 Hawthorn Advisors                               eden@hawthornadvisors.com

 Stephen Atkinson

 Victoria Ainsworth

 

Notes to Editors:

 

Eden Research is the only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative biopesticide
products and natural microencapsulation technologies to the global crop
protection, animal health and consumer products industries.

 

Eden's products are formulated with terpene active ingredients, based on
natural plant defence metabolites. To date, they have been primarily used on
high-value fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional pesticides.
Eden has two products currently on the market:

 

Based on plant-derived active ingredients, Mevalone® is a foliar
biofungicide which initially targets a key disease affecting grapes and other
high-value fruit and vegetable crops.  It is a useful tool in crop defence
programmes and is aligned with the requirements of integrated pest management
programmes. It is approved for sale in a number of key countries whilst Eden
and its partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.

 

Cedroz™( )is a bio-nematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and vegetable
crops globally. Cedroz is registered for sale on two continents and Eden's
commercial collaborator, Eastman Chemical, is pursuing registration and
commercialisation of this important new product in numerous countries
globally.

 

Eden's Sustaine(®)( )encapsulation technology is used to harness the
biocidal efficacy of naturally occurring chemicals produced by plants
(terpenes) and can also be used with both natural and synthetic compounds to
enhance their performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres derived from
yeast. It is one of the only viable, proven and immediately registerable
solutions to the microplastics problem in formulations requiring
encapsulation.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the
symbol EDEN. It was awarded the London Stock Exchange Green Economy
Mark in January 2021, which recognises London-listed companies that derive
over 50% of their total annual revenue from products and services that
contribute to the global green economy. Eden derives 100% of its total annual
revenues from sustainable products and services.

 

For more information about Eden, please visit:  www.edenresearch.com
(http://www.edenresearch.com/) .

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFFFSIAFILIIF